Masitinib (AB1010), a Potent and Selective Tyrosine Kinase Inhibitor Targeting KIT

BACKGROUND: The stem cell factor receptor, KIT, is a target for the treatment of cancer, mastocytosis, and inflammatory diseases. Here, we characterise the in vitro and in vivo profiles of masitinib (AB1010), a novel phenylaminothiazole-type tyrosine kinase inhibitor that targets KIT. METHODOLOGY/PR...

Descripción completa

Detalles Bibliográficos
Autores principales: Dubreuil, Patrice, Letard, Sébastien, Ciufolini, Marco, Gros, Laurent, Humbert, Martine, Castéran, Nathalie, Borge, Laurence, Hajem, Bérengère, Lermet, Anne, Sippl, Wolfgang, Voisset, Edwige, Arock, Michel, Auclair, Christian, Leventhal, Phillip S., Mansfield, Colin D., Moussy, Alain, Hermine, Olivier
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2746281/
https://www.ncbi.nlm.nih.gov/pubmed/19789626
http://dx.doi.org/10.1371/journal.pone.0007258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2746281/
https://www.ncbi.nlm.nih.gov/pubmed/19789626
http://dx.doi.org/10.1371/journal.pone.0007258

Ejemplares similares